Derivation of stem cell line UMi028-A-2 containing a CRISPR/Cas9 induced Alzheimer's disease risk variant p.S1038C in the TTC3 gene

Stem Cell Res. 2021 Apr:52:102258. doi: 10.1016/j.scr.2021.102258. Epub 2021 Feb 18.

Abstract

The UMi028-A-2 human induced pluripotent stem cell line carries a homozygous mutation (rs377155188, C>G, p.S1038C) in the tetratricopeptide repeat domain 3 (TTC3) gene that was introduced via CRISPR/Cas9 genome editing. The line was originally derived from a neurologically normal male and has been thoroughly characterized following editing. The p.S1038C variant has been shown to potentially contribute to the risk of late onset Alzheimer's disease and is a resource to further investigate the consequences of TTC3 and this alteration in disease pathology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / genetics
  • CRISPR-Cas Systems / genetics
  • Cell Line
  • Gene Editing
  • Humans
  • Induced Pluripotent Stem Cells*
  • Male
  • Ubiquitin-Protein Ligases

Substances

  • TTC3 protein, human
  • Ubiquitin-Protein Ligases